Auto logout in seconds.
Continue LogoutThe development of tumor site programs—programs meeting the specific needs of one tumor site population—has long been a priority for many cancer centers. Now, tumor site programs are taking on more importance than ever due to advances in treatment and changing patient demands.
This study describes the most significant developments in five tumor site programs: breast, lung, gynecologic, colorectal, and prostate. In addition, we've provided a suite of downloadable tools and resources to help you put our study into action.
Oncology programs are faced by surging demand: the number of new cancer cases in the U.S. is expected to grow by more than 25% over the next decade. At the same time, competition for these volumes has increased, and treatment innovations mean that cancer care is becoming more complex.
Tumor site programs, organized to help providers anticipate and meet patients’ diverse medical and psychosocial needs, are one response to these challenges. They can lead to higher quality, patient-centered care while also strengthening market strategy and supporting larger organizational goals. Read more about the importance of tumor site programs.
Breast cancer programs are the most common type of tumor site program. This chapter breaks down topics including the impact changes to screening guidelines will have on mammography volumes, innovations in radiation therapy, and survivorship services. Read more.
Over the next ten years, organizations will see lung cancer incidence grow significantly. This chapter explores topics including nodule management, thoracic and cardiothoracic surgeon benchmarks, and palliative care. Read more.
Gynecologic cancers account for 11% of new cancer cases among women. This chapter focuses on topics such as how to evaluate if a gynecologic oncology program is a smart investment, tactics to increase access to subspecialists, and telehealth strategies. Read more.
Colorectal cancer incidence is on the rise. This chapter covers strategies to improve colorectal cancer screening rates and ways to support patients’ nutritional needs. Read more.
Prostate cancer is one of the most common cancers in the U.S. This chapter digs into topics including collaborating with independent urologists to treat patients, emerging diagnostic technologies, and robot-assisted radical prostatectomy. Read more.
Our tumor site program resource grids outline the requirements for developing tumor site programs by disease site, and break down the services necessary to drive performance across the care continuum.
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece
Email ask@advisory.com to learn more
Never miss out on the latest innovative health care content tailored to you.
This is for members only. Learn more.
Never miss out on the latest innovative health care content tailored to you.